Literature DB >> 4886292

Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12.

G Lancini, R Pallanza, L G Silvestri.   

Abstract

The mechanism of action of rifampicin, an antibiotic which inhibits in vitro the polycondensation of ribonucleotides by ribonucleic acid (RNA) nucleotidyltransferase, was studied in vivo in Escherichia coli. It is argued that the inhibition of RNA nucleotidyltransferase represents the primary lesion and is responsible for the bactericidal effect. This conclusion is based on (i) the correlation between concentrations of the antibiotic which block in vivo incorporation of labeled uracil and the bactericidal concentrations, (ii) the evidence that the loss of viability of the cells immediately follows the block of RNA synthesis, and (iii) the observation that the reversal of the inhibition of RNA synthesis goes together with a reversal of the loss of viability.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4886292      PMCID: PMC249757          DOI: 10.1128/jb.97.2.761-768.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

1.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

2.  Rifampicin: a new rifamycin. I. Bacteriological studies.

Authors:  V Arioli; R Pallanza; S Furesz; G Carniti
Journal:  Arzneimittelforschung       Date:  1967-05

3.  Action of rifamycins on RNA polymerase.

Authors:  W Wehrli; J Nüesch; F Knüsel; M Staehelin
Journal:  Biochim Biophys Acta       Date:  1968-03-18

4.  Inhibition of DNA-dependent RNA synthesis by rifamycins.

Authors:  H Umezawa; S Mizuno; H Yamazaki; K Nitta
Journal:  J Antibiot (Tokyo)       Date:  1968-03       Impact factor: 2.649

5.  The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Authors:  G Hartmann; K O Honikel; F Knüsel; J Nüesch
Journal:  Biochim Biophys Acta       Date:  1967

6.  Mode of action of rafamycin on the RNA polymerase reaction.

Authors:  A Sippel; G Hartmann
Journal:  Biochim Biophys Acta       Date:  1968-03-18

7.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

  7 in total
  14 in total

Review 1.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

2.  Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.

Authors:  Sonia I Maffioli; Yu Zhang; David Degen; Thomas Carzaniga; Giancarlo Del Gatto; Stefania Serina; Paolo Monciardini; Carlo Mazzetti; Paola Guglierame; Gianpaolo Candiani; Alina Iulia Chiriac; Giuseppe Facchetti; Petra Kaltofen; Hans-Georg Sahl; Gianni Dehò; Stefano Donadio; Richard H Ebright
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

3.  Initiation of DNA synthesis: synthesis of phiX174 replicative form requires RNA synthesis resistant to rifampicin.

Authors:  R Schekman; W Wickner; O Westergaard; D Brutlag; K Geider; L L Bertsch; A Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

4.  Transduction of rifampin resistance in group A streptococci.

Authors:  J G Stuart; J J Ferretti
Journal:  J Bacteriol       Date:  1973-08       Impact factor: 3.490

5.  Synthesis of unmethylated deoxyribonucleic acid in a dnaB temperature-sensitive mutant of Escherichia coli starved for methionine.

Authors:  J C Bouché
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

6.  Ribonucleic acid polymerase induced by vaccinia virus: lack of inhibition by rifampicin and alpha-amanitin.

Authors:  F Costanzo; L Fiume; M La Placa; A Mannini-Palenzona; F Novello; F Stirpe
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

Review 7.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

Review 8.  Actions of the rifamycins.

Authors:  W Wehrli; M Staehelin
Journal:  Bacteriol Rev       Date:  1971-09

9.  Mechanism of action of rifampin on Mycobacterium smegmatis.

Authors:  R J White; G C Lancini; L G Silvestri
Journal:  J Bacteriol       Date:  1971-11       Impact factor: 3.490

10.  Lethal effect of rifampicin in Bacillus subtilis as a complicating factor in the assessment of the lifetime of messenger ribonucleic acid.

Authors:  J G Coote; D A Wood; J Mandelstam
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.